During the past decade, Zhoushan hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zhoushan hospital" are "Breast Neoplasm" (1 trials), "Inflammatory Breast Cancer" (1 trials), "Invasive Ductal Breast Cancer" (1 trials), "Mucinous Breast Cancer" (1 trials) and "Needle-free Injector" (1 trials). Many other conditions were trialed in "Zhoushan hospital" in a lesser frequency.

Most popular intervention types in "Zhoushan hospital" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (1 trials), "Epirubicin plus Cyclophosphamide" (1 trials), "Gonadotropin-releasing hormone agonist" (1 trials), "Insulin pen" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zhoushan hospital" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Zhoushan hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Zhoushan hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhoushan hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".